Research chemical is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-10-05. Numbers and descriptions here follow the published literature rather than marketing material.
Regulatory status varies by country and is not harmonized. Epitalon is not an approved drug in major Western jurisdictions. In some countries it is sold as a research chemical, and in others it has appeared in products marketed for other categories. This inconsistent status means that purity, labeling accuracy, and documentation differ widely between suppliers, and verification of identity and purity through independent analysis is the usual way buyers assess a given lot.
Epitalon appears in the literature primarily through a small number of research groups, most of them associated with the St. Petersburg Institute of Bioregulation and Gerontology. Publications describe cell culture experiments, animal studies, and a limited number of small human studies. Independent replication outside this network is sparse. As a result, reviews of the topic usually separate descriptive reports of observed effects from the question of whether those effects generalize, and they note the difficulty of comparing studies that use different preparations and endpoints.
Analytical characterization of epitalon relies on standard peptide methods. Reverse-phase high-performance liquid chromatography is used to assess purity, and mass spectrometry confirms identity by checking the observed mass against the expected value near 390 daltons. Amino acid analysis can verify composition. Because the peptide is short and hydrophilic, it elutes early on many reverse-phase columns, so method development often requires ion-pairing reagents to achieve adequate retention and resolution from related impurities.
The peptide is a synthetic analogue of epithalamin, a preparation extracted from bovine pineal glands. Investigators sought a short, chemically defined molecule that would reproduce some of the endocrine and gerontological observations attributed to the glandular extract. Proposed mechanisms centre on induction of telomerase activity, an effect reported in cultured human somatic cells in the early 2000s, together with influences on melatonin secretion and neuroendocrine regulation. Those mechanisms remain incompletely characterised, and the reported telomerase response has not been consistently reproduced by independent groups working in comparable systems.
Published work on this compound consists mainly of in vitro experiments, animal studies, and small clinical investigations, a substantial share of which appeared in Russian-language journals. Sample sizes are generally small, control conditions differ between studies, and several endpoints rely on markers whose clinical meaning is itself debated. Reviews of the longevity field treat the peptide as an early example of telomerase-directed research rather than an established intervention. Regulatory treatment varies by country: some jurisdictions place it under prescription controls, others treat it as a laboratory material, and importation may be restricted regardless of local status.
| Property | Value | Notes |
|---|---|---|
| Purity assessment | RP-HPLC | Reported as percent area, often ≥95% |
| Identity confirmation | Mass spectrometry | Observed mass compared with ~390 Da |
| Typical storage temperature | -20 °C or below | Lyophilized powder, desiccated |
| Reconstitution solvent | Sterile water or buffer | Acidic residues aid dissolution |
| Common synonyms | AEDG; epithalon | Spelling varies in literature |
Reference material is normally supplied as a lyophilised powder in a sealed vial. Product literature typically recommends storage at minus twenty degrees Celsius or colder, protected from light and moisture. Freeze-thaw cycling is usually avoided because repeated condensation can introduce water into the vial. Working solutions are commonly prepared fresh, aliquoted, and kept cold for short periods rather than stored at ambient temperature. Labelling the date of opening helps track how long a vial has been in use.
Solubility is high in water, phosphate-buffered saline and normal saline, a pattern that follows from the two acidic residues in the chain. The peptide dissolves poorly in non-polar solvents such as hexane or chloroform. Stock solutions are often prepared in water first and then diluted into the buffer of interest. Because the molecule is small and hydrophilic, filtration through a low-protein-binding membrane is usually straightforward, and visible particulates are uncommon in freshly made solutions.
Identity and purity are established with reversed-phase high-performance liquid chromatography and mass spectrometry. The chromatogram shows the main peak and any truncated or oxidised by-products, while the mass spectrum confirms the expected 390 dalton mass. Amino acid analysis can corroborate composition when a sample's origin is uncertain. Counterion content, particularly residual trifluoroacetate from purification, is frequently reported alongside purity because it shifts the net mass of the solid.
Epitalon is a synthetic tetrapeptide with the sequence alanine–glutamate–aspartate–glycine, commonly abbreviated AEDG. Its design traces to epithalamin, a peptide fraction prepared from bovine pineal gland extracts that researchers in Saint Petersburg began investigating in the 1970s. The compound has a molecular formula of C14H22N4O9 and a nominal molecular mass near 390 daltons. It holds no approved drug status in the United States or the European Union, and material sold under this name is generally offered as a research chemical rather than a finished pharmaceutical product.
Proposed mechanisms centre on cell-culture observations rather than a defined receptor interaction. Several reports describe increased expression of the telomerase catalytic subunit after exposure of cultured human cells, and the authors attributed the effect to short peptide fragments entering the nucleus and influencing gene transcription. No receptor for the tetrapeptide has been identified, and the free peptide is expected to be degraded rapidly by plasma peptidases. Whether any measurable fraction reaches intact tissues after administration remains an unresolved question rather than an established finding.
The published literature is dominated by a small number of research groups, much of it in Russian-language journals, and independent replication outside those groups is limited. Studies are typically small, use cultured cells or rodent models, and report endpoints that differ between papers, which makes comparison difficult. Large randomised human trials have not appeared in the indexed literature. Questions about absorption, distribution and clearance are therefore still treated as open in reviews that mention the compound.
Identity and purity are checked by reversed-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, where the peptide bond absorbs. Mass spectrometry confirms the expected mass and reveals whether truncation products or adducts are present. Acid hydrolysis followed by amino acid analysis gives the residue ratio, which should approximate one alanine, one glutamate, one aspartate and one glycine. Counter-ions such as acetate or trifluoroacetate remain in the dried product and lower net peptide content, so a stated purity figure on a label does not by itself describe how much peptide a vial holds.
Regulatory treatment differs by country. No formulation of epitalon holds a marketing authorisation as a medicine in the United States or the European Union, where material sold for laboratory use is handled as a research chemical and is not intended for human consumption. In Russia, several short peptide preparations from the same institute's peptide series are registered medicinal products, and epitalon appears in that national context. Elsewhere it is frequently offered as a cosmetic ingredient, a category with lighter requirements. Advertising claims about longevity or disease prevention are restricted in most jurisdictions, which limits how sellers describe the compound.
Recent research shows promising results in mortality and morbidity reductions when a state integrates drug monitoring programs with health information technologies and shares data through a centralized platform. The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act or the SUPPORT for Patients and Communities Act was introduced by the US House of Representatives on June 22, 2018, and was advanced on June 22, 2018. The bill includes Medicare and Medicaid reform in order to improve treatment, recovery, and prevention efforts while also strengthening the fight against synthetic drugs like fentanyl. In September 2018, the US Senate approved the SUPPORT for Patients and Communities Act (H.R. 6). The committee reached a final agreement on terms of the bill on September 25, 2018. The final agreement included provisions from multiple other acts, such as The Opioid Crisis Response Act of 2018, The Helping to End Addiction and Lessen (HEAL) Substance Use Disorders Act of 2018, and the Synthetics Trafficking and Overdose Prevention (STOP) Act of 2018. The House and The Senate passed the final draft on September 28 and October 3, respectively. President Donald Trump signed the package into law on October 28, 2018. In July 2019, English multinational consumer goods corporation Reckitt Benckiser, parent of US pharmaceutical company Indivior, agreed to pay $1.4 billion to the U.S.
== External links == Zeiss Official Page Comparison of early visual outcomes after low-energy SMILE, high-energy SMILE and LASIK for myopia and myopic astigmatism in the United States Frequently Asked Questions About Small Incision Lenticule Extraction (SMILE) | Official Zeiss Publication
== Outcomes and impact == The programme has been associated with improved child nutrition, increased milk consumption, and greater awareness of dairy’s benefits among Thai children. Economically, it stabilizes the dairy sector by guaranteeing a domestic market for local producers, accounting for more than 30 percent of Thailand’s liquid milk sales.
With the widespread interest in birds, use of a large number of people to work on collaborative ornithological projects that cover large geographic scales has been possible. These citizen science projects include nationwide projects such as the Christmas Bird Count, Backyard Bird Count, the North American Breeding Bird Survey, the Canadian EPOQ or regional projects such as the Asian Waterfowl Census and Spring Alive in Europe. These projects help to identify distributions of birds, their population densities and changes over time, arrival and departure dates of migration, breeding seasonality, and even population genetics. The results of many of these projects are published as bird atlases. Studies of migration using bird ringing or colour marking often involve the cooperation of people and organizations in different countries.
Sources: en.wikipedia.org
In series 3, Kenny is said to have helped Eric through a drinking problem following Eric's marital separation. Kenny also reveals he recently got married himself. Eric admits to Yasmin that he regrets showing Kenny a vulnerable side of himself. Eric, recently promoted to partner, is told by Adler that he needs to fire someone on the trading floor to prove his worth. Instead of firing Yasmin or Robert like he initially considered, Eric fires Kenny, threatening to expose his past treatment of Yasmin if he does not go quietly. Kenny is later shown to have joined Goldman Sachs alongside fellow ex-Pierpoint employees Daria Greenock and Jackie Walsh, and the three agree to help Harper short Pierpoint. In series 4, Kenny now works at Deutsche Bank, and Harper and Eric, now running their own hedge fund, enlist him to broker their short of payment processing startup Tender. Eric apologizes to Kenny for firing him. Kenny later tells Harper and Eric that they have breached their risk limits due to Tender's share price continuing to rise, forcing Deutsche to issue a margin call on their firm. Harper liquidates several of her firm's other positions to post more collateral, and sends Sweetpea and Kwabena to Accra in a last-ditch effort to uncover evidence against Tender. The Tender short is ultimately successful, and Harper calls Kenny to close the position after Tender's stock plummets, netting SternTao £110 million.
=== Troll Center case === In January 2016, the El Diario de Hoy and La Prensa Gráfica newspapers reported that the Búnker digital-programming company had created mirror sites of the newspapers in June 2015 and posted false information in an attempt to damage their reputations; the newspapers described the incident as a cyberattack. In a subsequent investigation by the office of the attorney general (FGR), Bukele allegedly instructed a Twitter user to create the mirror sites. Bukele denied involvement in the creation of the mirror sites. The incident became known as the "Troll Center" case. Five people were charged in relation to the case, but the charges were dropped in December 2017. On 4 July 2017, Bukele sued La Prensa Gráfica for $6 million, alleging that the newspaper had defamed and slandered him in its reporting of the cyberattacks by "falsely" ("falsamente") connecting him to the Troll Center case and "damag[ing] [Bukele's] image" ("dañó la imagen del señor alcalde"). Later that month, a court dismissed Bukele's lawsuit and three other courts rejected his appeals. In December 2018, the FGR stated that it had reviewed information supposedly linking Bukele's cell phone to the cyberattacks.
Turnout was 71.42 per cent. Of the 37,807,781 party-list ballots cast, 35,030,601 were valid, 1,669,006 were invalid and 1,108,051 were marked for no party. Bhumjaithai's strength in the constituencies was concentrated geographically. It led the party-list vote in 56 constituencies, compared with 215 for the People's Party, and won no seat in Bangkok, where the People's Party took all 33.
Sources: en.wikipedia.org
The 2nd Black Watch, with its Rhodesian contingent, took part in the unsuccessful Allied defence of Crete in May–June 1941, then joined the garrison at Tobruk in August 1941. No. 237 (Rhodesia) Squadron was re-equipped with Hawker Hurricanes the following month.
== Epidemiology == Leiomyosarcomas are rare. Sarcomas combined account for less than 1% of cancer diagnoses, and leiomyosarcoma accounts for around 10% of sarcoma diagnoses. Around 63% of uterine sarcomas, 20% of abdominal sarcomas, and 15% of sarcomas of the arms and legs are leiomyosarcomas. Non-uterine leiomyosarcoma is around 40% more common in women than in men. The disease generally affects older adults with the average person diagnosed around age 60. Uterine leiomyosarcoma most commonly impacts women in perimenopause, with an average age of diagnosis at 57.
== Diagnosis == There is no medical consensus on methodology of diagnosis for CMRD itself. There are, however, protocols used to diagnose the family of genetic disorders to which CMRD belongs. Assessment of hypobetalipoproteinemia relies chiefly on blood lipid analysis following a 12-hr fasting period. Lipids analyzed are LDL (low-density lipoproteins), triglyceride, and apolipoprotein B levels. A patient could be diagnosed with CMRD should they lack sufficient apolipoprotein B levels in the blood. Furthermore, a minimally invasive endoscopic procedure can be used to examine the bowel. A pale intestine can also be indicative of CMRD. Because patient outcomes rely on early diagnosis, it is recommended that candidates for the disorder should receive lipid panel testing prior to 6 months of age. In patients with only CMRD, lipid panels are expected to display normal triglyceride levels, but LDL and HDL levels may >50% below normal range. The test should also reveal low levels of Vitamin E and heightened levels of creatine kinase in the blood.
Sources: en.wikipedia.org
Identity is normally confirmed by mass spectrometry, which checks the measured mass against the expected value near 390 daltons. Reverse-phase high-performance liquid chromatography is used alongside it to assess purity. Amino acid analysis can provide additional composition data.
The powder is generally kept refrigerated or frozen, protected from light and moisture. Vials should reach room temperature before opening to prevent condensation. Reconstituted solutions are usually stored cold and used within a limited window because dilute solutions can degrade or support microbial growth.
Epitalon is not an approved drug in major Western regulatory jurisdictions. Its legal status differs between countries, and it is often distributed as a research chemical. This means product documentation and purity vary considerably between suppliers.
Epitalon is a synthetic four-amino-acid peptide with the sequence alanine–glutamate–aspartate–glycine, also written AEDG. It was developed in Russian gerontology research and is studied for proposed effects on telomerase, melatonin regulation, and neuroendocrine function. It is not an approved pharmaceutical in the United States or the European Union.